ClinicalTrials.Veeva

Menu

Search for Serum/Plasma Biomarkers in Pompe's Disease (BIOPOMPE)

F

Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau

Status

Unknown

Conditions

Late Onset Pompe Disease
Pompe Disease

Treatments

Drug: Enzyme Replacement Agent

Study type

Observational

Funder types

Other
Industry

Identifiers

NCT03045042
IIBSP-BIO-2017-02
GZ-2015-11342 (Other Identifier)

Details and patient eligibility

About

This study aims to analyze serum and plasma samples from patients with late onset Pompe disease treated and not treated with enzyme replacement therapy (ERT) to identify microRNA that could be specific of the disease. The investigators will correlate the concentration of these microRNA with several muscle function tests and quantitative muscle MRI to know whether they are good biomarkers of progression.

Enrollment

35 estimated patients

Sex

All

Ages

2+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Genetic confirmation of Pompe disease

Exclusion criteria

  • Pregnancy

Trial design

35 participants in 2 patient groups

Treated patients
Description:
Patients with late onset Pompe disease treated with the enzyme replacement therapy
Treatment:
Drug: Enzyme Replacement Agent
Non treated patients
Description:
Patients with late onset Pompe disease non treated with the enzyme replacement therapy

Trial contacts and locations

1

Loading...

Central trial contact

Jordi Díaz Manera, MD PhD; Eduard Gallardo, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems